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Clinical Blood Flow Quantification With Segmented 
k-Space Magnetic Resonance Phase Velocity 
Mapping 
George P. Chatzimavroudis, PhD,1,2* Haosen Zhang, MS,2 Sandra S. Halliburton, PhD,1,2 
James R. Moore, PhD,3 Orlando P. Simonetti, PhD,3 Paulo R. Schvartzman, MD,1 
Arthur E. Stillman, MD,1 and Richard D. White, MD1 
Purpose: To evaluate the accuracy of segmented k-space 
magnetic resonance phase velocity mapping (PVM) in 
quantifying aortic blood flow from through-plane velocity 
measurements. 
Materials and Methods: Two segmented PVM schemes were 
evaluated, one with seven lines per segment (seg-7) and one 
with nine lines per segment (seg-9), in twenty patients with 
cardiovascular disease. A non-segmented (non-seg) PVM ac­
quisition was also performed to provide the reference data. 
Results: There was agreement between the aortic flow curves 
acquired with segmented and non-segmented PVM. The cal­
culated systolic and total flow volume per cycle from the seg-7 
and the seg-9 scans correlated and agreed with the flow vol­
umes from the non-seg scans (differences < 5%). Sign tests 
showed that there were no statistically significant differences 
(P-values < 0.05) between the segmented and the non-seg­
mented PVM measurements. Seg-9, which was the fastest 
among the three sequences, provided adequate spatial and 
temporal resolution (> 10 phases per cycle). 
Conclusion: Segmented k-space PVM shows great clinical 
potential in blood flow quantification. 
Key Words: magnetic resonance imaging; magnetic reso­
nance phase velocity mapping; segmented k-space; blood 
flow; flow quantification; aorta; velocity 
velocity and flow. The technique is based on the prin­
ciple that, by using the proper bipolar magnetic field 
gradients in the direction of interest, the velocity of the 
spins in that direction can be encoded within the phase 
of the detected signal (1). There have been many in vitro 
and in vivo studies evaluating PVM for flow quantifica­
tion (2–17). For in vitro studies, the accuracy and pre­
cision of PVM was found to be consistently high, with 
errors lower than 10% (2–7). In vivo studies showed a 
good correlation between PVM and Doppler ultrasound 
or other flowmetric techniques (2,4,8–11). PVM has 
been extensively used to visualize and quantify cardiac, 
arterial, and venous blood flow with high precision 
(7,10–17). 
Conventional PVM involves a non-segmented gradi­
ent-echo sequence with bipolar velocity-encoding gra­
dients in the direction(s) of interest. The acquisition is 
prospectively or retrospectively ECG-gated to acquire a 
number of time-phases throughout the cardiac cycle. 
Only one line of k-space is acquired for each time-phase 
per cardiac cycle, resulting in a scanning time of several 
minutes (usually three to five minutes, depending on 
functional and imaging parameters) for acquisition of a 
single velocity direction in one imaging slice. Consider-
MAGNETIC RESONANCE (MR) phase velocity mapping 
(PVM) has been widely used clinically to measure blood mented, 
practical clinically. 
1Section of Cardiovascular Imaging, Division of Radiology, The Cleve­
ing that PVM measurements constitute only part of a 
complete cardiac MR examination and that new diag­
nostic approaches have involved multi-slice and multi­
directional velocity acquisitions (6,18,19), this non-seg­
single k-space line scheme becomes less 
With the development of rapid imaging sequences,
 
such as turbo gradient echo (TGE) and echo planar,
 
land Clinic Foundation, Cleveland, Ohio. faster PVM has become possible (20–31). Instead of a
 
cago, Illinois. the acquisition can be performed in seconds. Seg­
mented TGE has shown good flow-behavior and can 
provide high temporal and spatial resolution acquisi­
tions. It is, therefore, promising for reliable rapid flow 
quantification even in cases of moderately disturbed 
flow and vessel motion (25–31). 
In a recent in vitro study (31), we showed that seg­
mented k-space PVM provides accurate flow results 
under steady and pulsatile flow conditions (errors < 
5%). Segmented PVM measurements with five, seven, 
single k-space line, a segment of k-space lines are ac­
quired per time-phase and cardiac cycle. As a result, 
2
of Chemical Engineering, Cleveland State University, Cleveland, Ohio. 
3Magnetic Resonance Division, Siemens Medical Solutions USA, Chi-
Laboratory of Biofluid Mechanics and Cardiovascular Imaging, Department 
and nine k-space lines per segment agreed very closely 
with non-segmented measurements under identical ex­
perimental conditions. Therefore, the aim of the present 
study was to clinically evaluate segmented PVM as a 
blood flow quantification technique, by measuring 
blood flow in the human ascending aorta. Of interest 
was the effect of increasing the number of k-space lines 
per segment on the accuracy of the results. 
MATERIALS AND METHODS 
MR PVM measurements were performed in the ascend­
ing aorta of twenty patients with cardiovascular disease 
(16 males, average age 61 years; four females, average 
age 73 years) using a 1.5 Tesla whole-body MRI scanner 
(Sonata, Siemens Medical Solutions, Erlangen, Ger­
many) with a maximum gradient strength of 40 
mTesla/m. Thirteen patients had aortic dilatation and 
aneurysms (six with aortic regurgitation) with mid-as­
cending aorta diameter 4.5–6.0 cm. Six patients had 
ischemic heart disease (two with mitral regurgitation, 
one with combined aortic stenosis/aortic regurgita­
tion/mitral regurgitation). One patient had a left ven­
tricular aneurysm. The study protocol was approved by 
the Institutional Review Board of the Cleveland Clinic 
Foundation. 
Initial true-FISP (fast imaging with steady-state pre­
cession) scout images in all three spatial orientations 
(axial, coronal, and sagittal) showed the location of the 
ascending aorta. The through-plane velocity of blood 
was measured in an imaging slice placed perpendicular 
to the long-axis of the ascending aorta, at the level of 
pulmonary artery bifurcation. Three PVM acquisitions 
were performed, at the same location in each subject, 
using the following three sequences: (a) conventional 
non-segmented gradient echo (non-seg); (b) segmented 
TGE with seven k-space lines per time-phase and car­
diac cycle (seg-7); and (c) segmented TGE with nine 
lines per time-phase and cycle (seg-9). 
The non-seg scans were 120–180 seconds long, 
whereas the segmented scans were 10–16 seconds 
long, depending on the heart rate. Each of the seg­
mented k-space scans was performed during a breath-
hold. In all sequences, the flow-sensitive and the flow-
compensated data were acquired in an interleaved 
manner in the same cycle. The flip angle was 30°. The 
slice thickness was 5 mm. The scan percentage factor 
(percentage of k-space filled) was 75% for the non-seg 
scans, 55% for the seg-7 scans, and 56% for the seg-9 
scans. The 75% rectangular field of view (FOV) was 
varied from 210 � 280 mm2 to 263 � 350 mm2, de­
pending on patient size. Combination of the scan per­
centage factor with the rectangular FOV factor resulted 
in an acquired number of 144, 105, and 108 ky-lines for 
the non-seg, seg-7, and seg-9 scans, respectively. The 
nominal voxel size varied between 1.5 � 1.1 � 5.0 mm3 
and 1.8 � 1.4 � 5.0 mm3 for sequence (a), between 
2.0 � 1.1 � 5.0 mm3 and 2.5 � 1.4 � 5.0 mm3 for 
sequence (b), and between 1.9 � 1.1 � 5.0 mm3 and 
2.4 � 1.4 � 5.0 mm3 for sequence (c). Therefore, for a 
reconstructed matrix of 256 � 256, the interpolated 
voxel size varied from 1.1 � 1.1 � 5.0 mm3 to 1.4 � 
1.4 � 5.0 mm3 in all sequences. 
The shortest (2.3–3.0 msec) allowable echo time (TE) 
was used for all measurements. All acquisitions were 
prospectively ECG-gated, resulting in 19–35, 13–25, 
and 11–21 time-phases per cycle for the non-seg, seg-7, 
and seg-9 acquisitions, respectively. The temporal res­
olution of the segmented acquisitions was improved by 
using echo view-sharing (32). The resulting resolution 
was 30 msec, 40–46 msec, and 50–57 msec for the 
non-seg, seg-7, and seg-9 acquisitions, respectively. 
The time corresponding to each time-phase was the 
time of acquisition of the central line of the segment, 
since that line contained the most useful velocity infor­
mation of the segment. 
In the non-seg sequence, the repetition time (TR) was 
15 msec. In seg-7 and seg-9, the time to acquire data for 
any one ky-line (actual TR) varied between 5.2 msec and 
5.6 msec, depending on imaging parameters such as 
FOV. The echo was acquired asymmetrically within the 
data acquisition period. The peak of the echo occurred 
at data-point 82 of 256 and the missing data points 
were zero-filled. The velocity encoding value was 250 
cm/second. 
Each PVM acquisition produced a series of magni­
tude and phase images. All images were transferred to a 
work-station (Ultra-10, SUN Microsystems, Inc., Palo 
Alto, CA). A FORTRAN program was used to examine 
the images for the presence of any residual phase off­
sets (5,33). When phase offsets were detected, they were 
removed based on a two-dimensional regression anal­
ysis model, and the phase values of the phase images 
were converted to velocity values (cm/second), based 
on their proportionality. The images were further pro­
cessed using Transform (Version 3.4, Research Sys­
tems, Inc., Boulder, CO) to calculate the flow rates and 
flow volumes. The aortic cross-section was defined as 
the region of interest, and the velocity was integrated 
over the aortic cross-sectional area to determine the 
flow rate (mL/second) through the aorta for each time-
phase. Integration of the aortic flow curve over systole 
and over the entire cardiac cycle provided the systolic 
and total flow volumes (mL/cycle), respectively. When 
no phase offset was detected, the images were pro­
cessed using manufacturer software (ARGUS Cardiac 
Analysis, Siemens Medical Solutions, Erlangen, Ger­
many) in order to automatically calculate the flow rates 
and flow volumes. 
Statistical analysis, including non-parametric sign 
tests, regression analysis, and t-tests, was performed to 
compare the flow data from the segmented acquisitions 
with the flow data from the non-segmented acquisi­
tions. Most of the statistics was performed using 
Minitab (Version 13, Minitab, Inc., State College, PA). 
RESULTS 
Figure 1 shows representative magnitude and phase 
images from the non-seg and seg-9 PVM acquisitions 
from one subject at peak systole. Both sets of images 
are of sufficient quality for reliable analysis and flow 
quantification. Similar image quality was observed in 
all subjects for all three sequences used. 
Figure 1. Magnitude (left) and phase 
(right) images acquired in the same sub­
ject using the non-segmented sequence 
(top) and the segmented sequence with 
nine lines per segment (bottom). Both 
sets of images are of sufficient quality for 
flow quantification analysis. 
As expected, the seg-7 acquisitions provided higher 
temporal resolution than the seg-9 acquisitions (13–25 
time-phases for seg-7 vs. 11–21 time-phases for seg-9); 
however, seg-9 provided greater scanning speed (13–16 
seconds for seg-7 vs. 10–13 seconds for seg-9). 
The flow curves obtained using the segmented acqui­
sitions agreed with the curves obtained using the non-
segmented acquisitions, as seen in Figure 2 for four 
representative cases. In patients with aortic regurgita­
tion, the flow curves showed diastolic reverse flow ac­
tivity, as expected (e.g., subject 17, Fig. 2). Table 1 
shows all of the flow volume results. 
The results for the systolic and the total flow volumes 
from the segmented PVM acquisitions showed a close 
correlation (Pearson coefficients 2 0.94, Table 2) and 
agreement (mean difference < 5%) with those from the 
non-segmented acquisitions. Sign tests showed no sta­
tistically significant differences (P-values > 0.05) be­
tween the segmented and the non-segmented PVM 
measurements (Table 2). Figures 3 and 4 show the 
regression analysis results from the comparison be­
tween the segmented and the non-segmented systolic 
and total flow volumes, respectively. In all cases, the 
regression lines have slopes not significantly different 
from 1.0, and intercepts not significantly different from 
zero (as statistically determined via t-tests with P-val­
ues > 0.05). In addition, the coefficients of determina­
tion are large (r2 > 0.88), and the standard errors small 
(Table 2). Good correlation (Pearson coefficient 2 0.97, 
Table 2) and no statistically significant differences were 
also found between the seg-7 and seg-9 flow volume 
results (refer to the regression analysis and sign test 
results in Fig. 5 and Table 2). 
DISCUSSION 
Non-segmented MR PVM is an accurate and precise 
velocimetric and flow quantification technique, and has 
been used clinically to measure blood flow and charac­
terize blood flow patterns throughout the cardiovascu­
lar system. Despite its advantages, it is relatively slow, 
requiring several minutes for acquisition of a single 
velocity component in a slice. With the development of 
segmented k-space acquisition schemes, rapid PVM 
has become available. 
We recently evaluated the in vitro accuracy of seg­
mented PVM with five, seven, and nine lines per seg­
ment under a variety of flow conditions (31). The results 
showed that segmented k-space PVM has high potential 
for blood flow quantification. Based on the positive in 
vitro results, the aim of the present study was to clini­
cally evaluate the potential of segmented PVM to quan­
tify blood flow in the aorta of human subjects. We did 
not evaluate the segmented scheme with five lines per 
segment clinically, because it would generally require 
more than 20 seconds per acquisition. A breath-hold of 
such duration may be difficult to achieve for many pa­
tients. 
Due to the lack of a universally acceptable gold-
standard blood flow quantification technique, in this 
study we considered non-segmented PVM as the ref­
erence technique. This can be justified by the large 
number of previous evaluations of the non-seg­
mented technique both in vitro and in vivo. Therefore, 
a comparison between segmented and non-seg­
mented k-space PVM can provide important informa­
tion about the reliability of segmented PVM as a flow 
quantification technique. 
Image quality was good for all sequences used, facil­
itating image analysis and processing. The aortic cross-
section could easily be identified for further analysis. 
Although the in-plane spatial resolution (= 1–3 mm2) 
was adequate to obtain the details of the velocity profile 
for a large vessel such as the ascending aorta, an even 
Table 1 
Flow Volume Results 
Figure 2. Measured aortic 
flow waveforms in four sub­
jects using the non-seg­
mented sequence, and two 
segmented sequences with 
seven and nine k-space lines 
per segment. A good agree­
ment can be observed in all 
cases between the three se­
quences. 
higher resolution (however, at the expense of scanning 
time) would be required for smaller vessels, as previ­
ously observed in vitro (31). Higher spatial resolution 
would also better resolve the velocity gradients imme­
diately adjacent to the vessel wall (important to accu­
rately calculate wall shear stress). However, the effects 
of reducing voxel size on the signal-to-noise ratio and, 
thus, image quality in vivo need to be thoroughly inves­
tigated. 
The measured aortic flow curves in all subjects 
were very similar for all three sequences (non-seg, 
seg-7, and seg-9). It should be noted that, in seg-
Subject no. Systolic volume, ml/cycle 
Non-Seg Seg-7 Seg-9 Non-Seg 
Total volume, ml/cycle 
Seg-7 Seg-9 
1 90.1 91.7 90.3 88.1 90.8 86.1 
2 41.8 41.1 42.9 36.6 39.2 36.0 
3 55.8 58.4 59.4 36.8 37.2 33.7 
4 67.8 67.3 69.4 64.6 60.2 66.8 
5 57.5 61.9 58.9 57.0 58.8 58.3 
6 45.3 49 47.9 44.2 50.1 54.2 
7 67.9 67.9 68.9 67.1 64.1 62.6 
8 57.9 59.4 57.3 59.1 43.9 48.7 
9 52.4 49.1 48.5 48.4 47.8 46.4 
10 54.8 55.9 57 53.7 52.7 53.3 
11 63.8 63.7 64.3 58.5 57.4 61.0 
12 72.4 66.1 69.6 77.7 76.1 82.4 
13 68 64 67.2 60.5 67.1 68.4 
14 37.2 40.2 37.2 40.7 36.1 42.7 
15 48.5 48.3 47.3 39.9 36.6 36.3 
16 71.9 70.9 73.9 69.8 67.3 73.2 
17 72.2 77 78.3 53.9 50.5 51.8 
18 72.6 67.8 74.2 53.5 56.8 56.5 
19 66.2 65.1 64 68.0 70.2 71.4 
20 70.5 75.8 72.3 53.8 58.6 57.2 
Non-Seg = non-segmented; Seg-7 = segmented with seven lines per segment; Seg-9 = segmented with nine lines per segment. 
Table 2 
Regression Analysis and Other Statistics 
Y 
(mL/second) 
X 
(mL/second) 
Regression 
equation R
2 SE 
(mL/second) 
Mean % 
difference 
Sign test 
P-value 
Pearson 
correlation 
coefficient 
Systolic flow volume 
Seg-7 Non-Seg Y = 0.95 X + 3.38 0.937 3.2 0.8 1.0 0.97 
Seg-9 Non-Seg Y = 1.01 X - 0.14 0.970 2.3 1.1 0.2 0.99 
Seg-9 Seg-7 Y = 1.03 X - 1.40 0.964 2.6 0.5 0.8 0.98 
Total flow volume 
Seg-7 Non-Seg Y = 0.99 X + 0.26 0.885 5.0 -0.8 0.8 0.94 
Seg-9 Non-Seg Y = 1.02 X - 0.57 0.903 4.7 1.2 0.8 0.95 
Seg-9 Seg-7 Y = 1.00 X + 1.44 0.942 3.6 2.3 0.8 0.97 
SE = standard error; Seg-7 = segmented with seven lines per segment; Seg-9 = segmented with nine lines per segment; Non-Seg=non­
segmented. 
mented PVM with N lines per segment (where N is 
an odd number), the most influential information 
is contained in the central line of the segment, 
(N+1)/2, because this is the closest line of the seg­
ment to the center of k-space. Therefore, the time 
point corresponding to each cardiac phase was 
adjusted to be the time of acquisition of the cen­
tral k-space line of the segment. As a result, the 
segmented techniques cannot acquire data at the 
very beginning of the cardiac cycle when they are 
prospectively ECG-gated (in this study, the first 
time phase in the cycle corresponded to 8, 40, and 
50 msec after the QRS wave, for the non-seg, seg­
7, and seg-9 acquisitions, respectively). This may 
cause uncertainties in measurements for patients 
with very rapid early systolic flow acceleration. Use of 
retrospective ECG-gating should eliminate this prob­
lem. 
The seg-7 and seg-9 flow volume (systolic and total) 
results showed strong correlation and agreement 
with the non-seg flow volume results, suggesting that 
reliable blood flow quantification is possible using 
ultra-fast segmented PVM. Increasing the number of 
k-space lines per segment to nine did not adversely 
affect the ability to sufficiently resolve the flow wave­
forms. The seg-9 scans were faster than the seg-7 
scans by approximately three seconds, and provided 
acquisitions with good temporal resolution (> 10 time 
phases per cycle). Increasing the number of k-space 
lines per segment above nine will certainly shorten 
the acquisition even more, but at the expense of tem­
poral resolution. Reducing the temporal resolution 
may cause uncertainties in determining local velocity 
values such as peak systolic velocities. Therefore, the 
number of lines should be further increased only 
Figure 3. Comparison between the systolic flow volumes mea­
sured with the non-segmented and the two segmented se­
quences (non-Seg: non-segmented acquisition; Seg-7: seg­
mented acquisition with seven k-space lines per segment; 
Seg-9: segmented acquisition with nine k-space lines per seg­
ment). The diagonal line is the line of identity. 
Figure 4. Comparison between the total flow volumes mea­
sured with the non-segmented and the two segmented se­
quences (non-Seg: non-segmented acquisition; Seg-7: seg­
mented acquisition with seven k-space lines per segment; 
Seg-9: segmented acquisition with nine k-space lines per seg­
ment). The diagonal line is the line of identity. 
Figure 5. Comparison between the flow volumes (systolic and 
total) measured with the two segmented sequences (Seg-7: 
segmented acquisition with seven k-space lines per segment; 
Seg-9: segmented acquisition with nine k-space lines per seg­
ment). The diagonal line is the line of identity. 
after assuring acquisition of an adequate number of 
time phases per cycle to prevent loss of valuable in­
formation and evaluating the acquisition technique 
in vitro and in vivo. 
In conclusion, segmented k-space magnetic reso­
nance phase velocity mapping in the human ascend­
ing aorta produced flow results that agreed with 
those from non-segmented acquisitions. Increasing 
the number of lines per segment to nine allowed 
very fast acquisitions (< 15 seconds) with adequate 
temporal resolution (less than 60 msec between suc­
cessive time phases). Segmented k-space MRPVM 
shows great clinical potential in blood flow quantifi­
cation. 
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